Immunohistochemistry for human telomerase reverse transcriptase catalytic subunit hTERT: A study of 143 benign and malignant soft tissue and bone tumours

Pathology

Volumn 41, Issue 6, 2009, Pages 527-532

  Patel, Rajiv M ^a   Folpe, Andrew L ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Bone tumours; HTERT; Immunohistochemistry; Sarcomas; Soft tissue tumours; Telomerase

Indexed keywords

EPITOPE; TELOMERASE REVERSE TRANSCRIPTASE;

ANGIOSARCOMA; ARTICLE; BASAL CELL; BONE TUMOR; CANCER GRADING; CHONDROMA; CONTROLLED STUDY; ENZYME ACTIVE SITE; HISTIOCYTE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; LIPOSARCOMA; LIVER CELL; LYMPHOCYTE; NERVE SHEATH TUMOR; NEURILEMOMA; OSTEOSARCOMA; PROTEIN EXPRESSION; RESPIRATORY TRACT MUCOSA; SARCOMA; SOFT TISSUE TUMOR;

EID: 70350624368     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1080/00313020903121614     Document Type: Article

References (29)

1. Yan P, Benhattar J, Seelentag W, et al. Immunohistochemical localization of hTERT protein in human tissues. Histochem Cell Biol 2004; 121: 391-397
2. Martin JA, DeYoung BR, Gitelis S, et al. Telomerase reverse transcriptase subunit expression is associated with chondrosarcoma malignancy. Clin Orthop Relat Res 2004; 426: 117-124
3. Schneider-Stock R, Boltze C, Jager V, et al. Elevated telomerase activity, c-MYC-, and hTERT mRNA expression: association with tumour progression in malignant lipomatous tumours. J Pathol 2003; 199: 517-525
4. Guillou L, Coindre JM, Bonichon F, et al. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcomas. J Clin Oncol 1997; 15: 350-362
5. Hiyama E, Hiyama K, Yokoyama T, et al. Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 2001; 3: 17-26.
6. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011-2015
7. Holt SE, Shay JW. Role of telomerase in cellular proliferation and cancer. J Cell Physiol 1999; 180: 10-18
8. Kovacs RB, Bollmann M, Speich N, et al. Measuring telomerase activity in various human tumors in routine histology and cytology. Int J Mol Med 2004; 13: 303-309
9. Yan P, Coindre JM, Benhattar J, et al. Telomerase activity and human telomerase reverse transcriptase mRNA expression in soft tissue tumors: correlation with grade, histology, and proliferative activity. Cancer Res 1999; 59: 3166-3170
10. Aogi K, Woodman A, Urquidi V, et al. Telomerase activity in softtissue and bone sarcomas. Clin Cancer Res 2000; 6: 4776-4781
11. Bovee JV, van Den Broek LJ, Cleton-Jansen AM, et al. Chondrosarcoma is not characterized by detectable telomerase activity. J Pathol 2001; 193: 354-360
12. Kido A, Schneider-Stock R, Hauptmann K, et al. Telomerase activity in benign bone tumors and tumor-like lesions. Pathol Res Pract 1999; 195: 753-757
13. Kleideiter E, Schwab M, Friedrich U, et al. Telomerase activity in cell lines of pediatric soft tissue sarcomas. Pediatr Res 2003; 54: 718-723
14. Martin JA, Forest E, Block JA, et al. Malignant transformation in human chondrosarcoma cells supported by telomerase activation and tumor suppressor inactivation. Cell Growth differ 2002; 13: 397-407.
15. Sanders RP, Drissi R, Billups CA, et al. Telomerase expression predicts unfavorable outcome in osteosarcoma. J Clin Oncol 2004; 22: 3790-3797 (Pubitemid 41095220)
16. Sangiorgi L, Gobbi GA, Lucarelli E, et al. Presence of telomerase activity in different musculoskeletal tumor histotypes and correlation with aggressiveness. Int J Cancer 2001; 95: 156-161
17. Schneider-Stock R, Rys J, Jaeger V, et al. Prognostic significance of telomerase activity in soft tissue sarcomas. Int J Oncol 1999; 15: 775-780
18. Terasaki T, Kyo S, Takakura M, et al. Analysis of telomerase activity and telomere length in bone and soft tissue tumors. Oncol Rep 2004; 11: 1307-1311
19. Tomoda R, Seto M, Tsumuki H, et al. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors. Cancer 2002; 95: 1127-1133
20. Umehara N, Ozaki T, Sugihara S, et al. Influence of telomerase activity on bone and soft tissue tumors. J Cancer Res Clin Oncol 2004; 130: 411-416
21. Yan P, Benhattar J, Coindre JM, et al. Telomerase activity and hTERT mRNA expression can be heterogeneous and does not correlate with telomere length in soft tissue sarcomas. Intl J Cancer 2002; 98: 851-856
22. Yoo J, Robinson RA. Expression of telomerase activity and telomerase RNA in human soft tissue sarcomas. Arch Pathol Lab Med 2000; 124: 393-397
23. Schneider-Stock R, Jaeger V, Rys J, et al. High telomerase activity and high HTRT mRNA expression differentiate pure myxoid and myxoid/ round-cell liposarcomas. Int J Cancer 2000; 89: 63-68
24. Hiyama E, Hiyama K. Clinical utility of telomerase in cancer. Oncogene 2002; 21: 643-649
25. Volpi A, Bravaccini S, Medri L, et al. Usefulness of immunological detection of the human telomerase reverse transcriptase. Cell Oncol 2005; 27: 347-353
26. Wu YL, Dudognon C, Nguyen E, et al. Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths. J Cell Sci 2006; 119: 2797-2824
27. Sabah M, Cummins R, Leader M, Kay E. Expression of human telomerase reverse transcriptase in gastrointestinal stromal tumors occurs preferentially in malignant neoplasms. Hum Pathol 2004; 35: 1231-1235
28. Fullen DR, ZhuW, Thomas D, et al. hTERT expression in melanocytic lesions: an immunohistochemical study on para.n-embedded tissue. J Cutan Pathol 2005; 32: 680-684
29. Sabah M, Cummins R, LeaderM, et al. Immunohistochemical detection of hTERT protein in soft tissue sarcomas. Appl Immunohistochem Mol Morphol 2006; 14: 198-202.